Biblio Discovery — Demo Discovery Service

37 results for "Molimard, Mathieu"

Showing 1–20 · 0.93 seconds · RSS

  1. Journal Article Full text

    Inhaler Devices for Chronic Obstructive Pulmonary Disease: Insights from Patients and Healthcare Practitioners

    Molimard, Mathieu; Colthorpe, Paul

    J Aerosol Med Pulm Drug Deliv · 2015 · English · PubMed Central

    Background: The choice of inhaler device for patients with chronic obstructive pulmonary disease (COPD) depends upon multiple attributes. An online survey was devised to assess COPD patients' and healthcare practitioners' (HCPs; physicians and nurses) opinions and preferences for inhaler devices…

  2. Journal Article Full text

    Performance Characteristics of Breezhaler(®) and Aerolizer(®) in the Real-World Setting

    Molimard, Mathieu; Kottakis, Ioannis; Jauernig, Juergen et al.

    Clin Drug Investig · 2021 · English · PubMed Central

    The evaluation of errors in use with different inhaler devices is challenging to quantify as there are a number of definitions of critical and non-critical errors with respect to inhaler use; in addition, performance characteristics of the device, such as airflow resistance, can also influence…

  3. Journal Article Full text

    Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects?

    Freyburger, Geneviève; Macouillard, Gérard; Khennoufa, Karim et al.

    Blood Coagul Fibrinolysis · 2015 · English · PubMed Central

    The aim of this study was to improve knowledge of what happens in the coagulation of orthopaedic patients under rivaroxaban and apixaban, in order to finalize and cross-validate effective measurement methods and to provide arguments for helping to reference one or the other drug in our central…

  4. Journal Article Full text

    Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study

    Latry, Philippe; Molimard, Mathieu; Dedieu, Bernard et al.

    BMC Cardiovasc Disord · 2011 · English · PubMed Central

    BACKGROUND: While the factors for poor adherence for treatment with statins have been highlighted, the impact of their combination on adherence is not clear. AIMS: To estimate adherence for statins and whether it differs according to the number of cardiovascular risk factors. METHODS: A cohort…

    Also available at: DOAJ

  5. Journal Article Full text

    Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

    Lechevallier-Michel, Nathalie; Molimard, Mathieu; Dartigues, Jean-François et al.

    Br J Clin Pharmacol · 2005 · English · PubMed Central

    OBJECTIVES: To measure the association between the use of drugs with anticholinergic properties and cognitive performance in an elderly population, the PAQUID cohort. METHODS: The sample studied was composed of 1780 subjects aged 70 and older, living at home in South western France. Data on…

  6. Journal Article Full text

    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study

    Humbert, Marc; Taillé, Camille; Mala, Laurence et al.

    Eur Respir J · 2018 · English · PubMed Central

    Omalizumab is a monoclonal anti-IgE antibody used to treat severe allergic asthma (SAA). The aim of the STELLAIR study was to determine the importance of pre-treatment blood eosinophil count as a predictive measure for response to omalizumab. This retrospective real-life study was conducted in…

  7. Journal Article Full text

    Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study

    Just, Jocelyne; Thonnelier, Celine; Bourgoin-Heck, Melisande et al.

    J Asthma Allergy · 2021 · English · PubMed Central

    BACKGROUND: Immunoglobulin (Ig) E-mediated pathophysiological mechanisms are common in allergic diseases including severe allergic asthma (SAA). The anti-IgE monoclonal antibody omalizumab may be particularly beneficial for patients with SAA and multiple allergic comorbidities (AC) including…

  8. Journal Article Full text

    Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions

    Arimone, Yannick; Miremont-Salamé, Ghada; Haramburu, Françoise et al.

    Br J Clin Pharmacol · 2007 · English · PubMed Central

    AIMS: To evaluate agreement between five senior experts when assessing seven causality criteria and the probability of drug causation. METHODS: A sample of 31 adverse event-drug pairs was constituted. For each pair, five experts separately assessed (i) the probability of drug causation, which was…

  9. Journal Article Full text

    Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy

    Carrié, Cédric; Delzor, Faustine; Roure, Stéphanie et al.

    Antimicrob Agents Chemother · 2020 · English · PubMed Central

    The aim was to assess the appropriateness of recommended regimens for empirical MIC coverage in critically ill patients with open-abdomen and negative-pressure therapy (OA/NPT). Over a 5-year period, every critically ill patient who received amikacin and who underwent therapeutic drug monitoring…

  10. Journal Article Full text

    Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real life

    Taillé, Camille; Humbert, Marc; Bourdin, Arnaud et al.

    ERJ Open Res · 2024 · English · PubMed Central

    Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, their asthma being under control. https://bit.ly/49ixpxt

  11. Journal Article Full text

    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients

    Humbert, Marc; Bourdin, Arnaud; Taillé, Camille et al.

    Eur Respir J · 2022 · English · PubMed Central

    BACKGROUND: This real-life study aimed to assess omalizumab treatment patterns in adult and paediatric asthma patients, and to describe asthma control and healthcare resource use (HCRU) at omalizumab initiation and discontinuation. METHODS: The French healthcare database system (Système National…

  12. Journal Article Full text

    Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study

    Villa, Antoine; Molimard, Mathieu; Bignon, Emmanuelle et al.

    BMJ Open · 2019 · English · PubMed Central

    INTRODUCTION: Antineoplastic drugs (AD) are potentially carcinogenic and/or reprotoxic molecules. Healthcare professionals are increasingly exposed to these drugs and can be potentially contaminated by them. Internal contamination of professionals is a key concern for occupational physicians in the…

  13. Journal Article Full text

    Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)

    Demoly, Pascal; Molimard, Mathieu; Bergmann, Jean-François et al.

    Lancet Reg Health Eur · 2024 · English · PubMed Central

    BACKGROUND: The only disease-modifying treatment currently available for allergic rhinitis (AR) is allergen immunotherapy (AIT). The main objective of the EfficAPSI real-world study (RWS) was to evaluate the impact of liquid sublingual immunotherapy (SLIT-liquid) on asthma onset and evolution in AR…

  14. Journal Article Full text

    Development and Validation of a LC‐MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment

    Rakotovao, Cedric; Sharanek, Ahmad; Burban, Audrey et al.

    Biomed Chromatogr · 2025 · English · PubMed Central

    Therapeutic drug monitoring of protein kinase inhibitors is widely practiced worldwide. Based on the example of ripretinib dosage requested by a clinician, we detailed the process of method development, using a literature‐based approach while ensuring the sustainability of the method to be as…

  15. Journal Article Full text

    Comorbidities and COPD severity in a clinic-based cohort

    Raherison, Chantal; Ouaalaya, El-Hassane; Bernady, Alain et al.

    BMC Pulm Med · 2018 · English · PubMed Central

    BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality around the world. The aim of our study was to determine the association between specific comorbidities and COPD severity. METHODS: Pulmonologists included patients with COPD using a web-site…